Podcast

Governor Larry Hogan 'Still Standing' After Cancer

Author(s):

Jessica Skarzynski

In this week’s episode of the CURE Talks Cancer podcast, Maryland Governor Larry Hogan opens up about what it was like to go through cancer not once but twice, and why he considers every day a gift.

In 2015, Maryland Governor Larry Hogan had only been in office for five months when he was diagnosed with an advanced, aggressive form of non-Hodgkin’s lymphoma. Then, after achieving remission, he was diagnosed with a common form of skin cancer in 2018.

But thanks to an attentive health care team, and the help of his friends, family and fellow patients, today he’s cancer-free and sharing his story.

In this week’s episode of the CURE® Talks Cancer podcast, Governor Hogan spoke with us about what it was like to go through cancer not once but twice, and why he considers every day a gift.

Related Videos
Dr. Sattva S. Neelapu is a professor and deputy department chair in the Department of Lymphoma/Myeloma, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center, in Houston, as well as a member of Graduate Faculty, Immunology Program, Graduate School of Biomedical Sciences, at The University of Texas Health Science Center, also located in Houston.
Dr. Sattva S. Neelapu, a professor and deputy department chair in the Department of Lymphoma/Myeloma, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center, in Houston, as well as a member of Graduate Faculty, Immunology Program, Graduate School of Biomedical Sciences, at The University of Texas Health Science Center, also located in Houston.
Dr Sattva S. Neelapu discusses data from the ZUMA-5 trial investigating the CAR T-cell therapy Yescarta in relapsed/refractory follicular lymphoma
Image of a woman with a brown hair tied into a bun.
Related Content
An image of a doctor taking notes.
January 24th 2025

Whitesnake Guitarist John Sykes Died of Cancer, Mike Peters Starting CAR-T

Alex Biese
From the deaths of John Sykes and former Planned Parenthood President Cecile Richards to an update from Mike Peters, here’s this week’s cancer news.
cancer horizons logo: a white microphone on a navy blue background
March 11th 2024

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
Illustration of blood cells.
January 21st 2025

Glucarpidase May Improve Renal Outcomes in Lymphoma, Leukemia

Ryan Scott
Patients with lymphoma or leukemia with methotrexate-induced acute kidney injury experienced improved renal outcomes following glucarpidase treatment.
cancer horizons podcast logo: a white microphone on a blue background
March 4th 2024

Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

Alex Biese Brielle Benyon
In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, and how to manage them.
CAR-T Cell Therapy in Hematologic Malignancies
January 6th 2025

Understanding the Intricacies of CAR-T Cell Therapy and Care in Hematologic Malignancies

Ryan Scott
Dr. Sattva S. Neelapu discusses the intricacies of CAR T-cell therapy treatment and care for patients with hematologic malignancies.
Illustration of woman with brown curly hair.
January 2nd 2025

Survivor’s Guilt: Asking, ‘Why Me?’

Karen Cohn
Despite being declared cancer-free after initial treatment, I grapple with survivor's guilt, questioning why my lymphoma responded to therapy while others did not.